Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Syndax Pharmaceuticals (SNDX) Other Operating Expenses (2019)

Syndax Pharmaceuticals has reported Other Operating Expenses over the past 1 years, most recently at $8.3 million for Q2 2019.

  • Quarterly results put Other Operating Expenses at $8.3 million for Q2 2019, changed N/A from a year ago — trailing twelve months through Mar 2020 was $8.3 million (changed N/A YoY), and the annual figure for FY2025 was $1.3 million, up 419.43%.
  • Other Operating Expenses for Q2 2019 was $8.3 million at Syndax Pharmaceuticals.
  • Over the last five years, Other Operating Expenses for SNDX hit a ceiling of $8.3 million in Q2 2019 and a floor of $8.3 million in Q2 2019.